Enhancing the Detection and Care of Heterozygous Familial Hypercholesterolemia in Primary Care: Cost-Effectiveness and Return on Investment.
Clara MarquinaJedidiah I MortonTom BrettMelanie A LloydJanette RadfordClare F HealCharlotte Mary HespeGerard GillDavid R SullivanElla ZomerIan W LiJing PangGerald F WattsZanfina AdemiPublished in: Circulation. Genomic and precision medicine (2023)
An enhanced general practitioner-led model of care for HeFH is likely to be cost-effective.